Age-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from montana immunized with a licensed polysaccharide vaccine

Infection and Immunity

Volumn 66, Issue 6, 1998, Pages 2453-2459

  Maslanka, Susan E ^a,c   Tappero, Jordan W ^a   Plikaytis, Brian D ^a   Brumberg, Robert S ^a,d   Dykes, Janet K ^a   Gheesling, Linda L ^a   Donaldson, Kimberley B J ^a   Schuchat, Anne ^a   Pullman, John ^b   Jones, Maryann ^b   Bushmaker, Julie ^b   Carlone, George M ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b Saint James Community Hospital   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Nova Southeastern University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIUM ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MENAMUNE; MENINGOCOCCUS VACCINE; MONOCLONAL ANTIBODY; POLYSACCHARIDE VACCINE; UNCLASSIFIED DRUG;

ADULT; AGE; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; SEROCONVERSION; SERUM BACTERICIDAL ACTIVITY; UNITED STATES;

EID: 0031813368     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.6.2453-2459.1998     Document Type: Article

References (40)

1. Agbarakwe, A. E., H. Griffiths, N. Begg, and H. M. Chapel. 1995. Avidity of specific IgG antibodies elicited by immunization against Haemophilus influenzae typc b. J. Clin. Pathol. 48:206-209.
2. Amir, j., M. G. Scott, M. H. Nahm, and D. M. Granoff. 1990. Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies to Haemophilus influenzae type b. J. Infect. Dis. 162:163-171.
3. Artenstein, M. S., R. Gold, J. G. Zimmerly, F. A. Wyle, H. Schneider, and C. Harkins. 1970. Prevention of meningococcal disease by group C polysaccharide vaccine. N. Engl. J. Med. 282:417-420.
4. Brandt, B. L., and M. S. Artenstein. 1975. Duration of antibody responses after vaccination with group C Neisseria meningitidis polysaccharide. J. Infect. Dis. 131S:S69-S72.
5. Cadoz, M., J. Armand, F. Arminjon, R. Gire, and C. Lafaix. 1985. Tetravalent (A,C.Y, W 135) meningococcal vaccine in children: immunogenicity and safety. Vaccine 3:340-342.
6. Carlone, G. M., J. D. Wenger, B. A. Perkins, S. E. Maslanka, and T. Popovic. 1997. Haemophilus influenzae type b, Neisseria meningitidis, Streptococcus pneumoniae, and Corynebacterium diphtheriae vaccines, p. 458-169. In N. R. Rose, E. Conway de Macario, J. D. Folds, H. C. Lane, and R. M. Nakamura (ed.), Manual of clinical laboratory immunology, 5th ed. ASM Press, Washington, D.C.
7. Fairley, C. K., N. Begg, R. Borrow, A. J. Fox, D. M. Jones, and K. Cartwright. 1996. Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants. J. Infect. Dis. 174:1360-1363.
8. Gheesling, L. L., G. M. Carlone, L. B. Pais, P. F. Holder, S. E. Maslanka, B. D. Plikaytis, M. Achtman, P. Densen, C. E. Frasch, H. Käyhty, J. P. Mays, L. Nencioni, C. Peeters, D. C. Phipps, J. T. Poolman, E. Rosenqvist, G. R. Siber, B. Thiesen, J. Tai, C. M. Thompson, P. P. Vella, and J. D. Wenger. 1994. Multicenter comparison of Neisseria meningitidis serogroup C anticapsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. J. Clin. Microbiol. 32:1475-1482.
9. Gold, R., M. L. Lepow, I. Goldschneider, T. F. Draper, and E. C. Gotschlich. 1979. Kinetics of antibody production to group A and group C meningococcal polysaccharide vaccines administered during the first six years of life: prospects for routine immunization of infants and children. J. Infect. Dis. 140:690-697.
10. Goldschneider, I., E. C. Gotschlich, and M. S. Artenstein. 1969. Human immunity to the meningococcus. I. The role of humoral antibodies. J. Exp. Med. 129:1307-1326.
11. Gotschlich, E. C., I. Goldschneider, and M. S. Artenstein. 1969. Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers. J. Exp. Med. 129: 1367-1384.
12. Griffis, J. M., and M. A. Bertram. 1977. Immunoepidemiology of meningococcal disease in military recruits. II. Blocking of serum bactericidal activity by circulating IgA early in the course of invasive disease. J. Infect. Dis. 136:733-739.
13. Hetherington, S. V., and M. L. Lepow. 1992. Correlation between antibody affinity and serum bactericidal activity in infants. J. Infect. Dis. 165:753-756.
14. Holder, P. K., S. E. Maslanka, L. B. Pais, J. Dykes, B. D. Plikaytis, and G. M. Carlone. 1995. Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992. Clin. Diagn. Lab. Immunol. 2:132-137.
15. Jackson, L. A., A. Schuchat, M. W. Reeves, and J. D. Wenger. 1995. Serogroup C meningococcal outbreaks in the United States. An emergine threat. JAMA 273:383-389.
16. Käyhty, H. 1980. Comparison of passive hemagglutination, bactericidal activity, and radioimmunological methods in measuring antibody responses to Neisseria meningitidis group A capsular polysaccharide vaccine. J. Clin. Microbiol. 12:256-263.
17. King, W. J., N. E. MacDonald, G. Wells, J. Huang, U. Allen, F. Chan, W. Ferris, F. Diaz-Mitoma, and F. Ashton. 1996. Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children. J. Pediatr. 128:196-202.
18. Leach, A., P. A. Twumasi, S. Kumah, W. S. Banya, S. Jaffar, B. D. Forrest, D. M. Granoff, D. E. LiButti, G. M. Carlone, L. B. Pais, C. V. Broome, and B. M. Greenwood. 1997. Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. J. Infect. Dis. 175:200-204.
19. Lepow, M. L., J. Beeler, M. Randolph, J. S. Samuelson, and W. A. Hankins. 1986. Reactogenicity and immunogenicity of a quadrivalent combined meningococcal polysaccharide vaccine in children. J. Infect. Dis. 154:1033-1036.
20. Lucas, A. H., and D. M. Granoff. 1995. Functional differences in idiotypically defined IgG1 anti-polysaccharide antibodies elicited by vaccination with Haemophilus influenzae type B polysaccharide-protein conjugates. J. Immunol. 154:4195-4202.
21. Mannik, M., and D. E. Stage. 1971. Antibodv-agarose immunoadsorbents: complete removal of classes of immunoglobulins from serum. J. Immunol. 106:1670-1672.
22. Maslanka, S. E., L. L. Gheesling, D. E. Libutti, K. B. J. Donaldson, H. S. Harakeh, J. K. Dykes, F. F. Arhin, S. J. N. Devi, C. E. Frasch, J. C. Huang, P. Kriz-Kuzemenska, R. D. Lemmon, M. Lorange, C. C. A. M. Peeters, S. Quataert, J. Y. Tai, G. M. Carlone, and The Multilaboratory Study Group. 1997. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. Clin. Diagn. Lab. Immunol. 4:156-167.
23. Milagres, L. G., A. P. S. Lemos, C. E. A. Meles, E. L. Silva, L. H. M. L. Ferreira, J. A. M. Souza, and G. M. Carlone. 1995. Antibody response after immunization of Brazilian children with serogroup C meningococcal polysaccharide noncovalently complexed with outer membrane proteins. Braz. J. Med. Biol. Res. 28:981-989.
24. Mitchell, L. A., J. J. Ochnio, C. Glover, A. Y. Lee, M. K. K. Ho, and A. Bell. 1996. Analysis of meningococcal serogroup C specific antibody levels in British Columbian children and adolescents. J. Infect. Dis. 173:1009-1013.
25. Nicholson, A., and I. H. Lepow. 1979. Host defense against Neisseria meningitidis requires a complement-dependent bactericidal activity. Science 205: 298-299.
26. Peltola, H., P. H. Mäkelä, H. Käyhty, H. Jousimies, E. Herva, K. Hällström, A. Sivonen, O. Renkonen, O. Pettay, V. Karankp, P. Ahvonen, and S. Sarna. 1977. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N. Engl. J. Med. 297:686-691.
27. Plikaytis, B. D., P. F. Holder, L. B. Pais, S. E. Maslanka, L. L. Gheesling, and G. M. Carlone. 1994. Determination of parallelism and nonparallelism in bioassay dilution curves. J. Clin. Microbiol. 32:2441-2447.
28. Reimer, C. B., D. J. Phillips, C. H. Aloisio, D. D. Moore, G. G. Galland, T. W. Wells, C. M. Black, and J. S. McDougal. 1984. Evaluation of thirty-one mouse monoclonal antibodies to human Ig epitopes. Hybridoma 3:263-275.
29. Rijkers, G. R., L. A. M. Sanders, and B. J. M. Zegers. 1993. Anti-capsular polysaccharide antibody deficiency states. Immunodeficiency 5:1-21.
30. Schlesinger, Y., D. M. Granoff, and the Vaccine Study Group. 1992. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. JAMA 267:1489-1494.
31. Schumaker, V. N., M. A. Calcott, H. L. Spiegelberg, and H. J. Müller-Eberhard. 1976. Ultracentrifuge studies of the binding of IgG of different subclasses to the C1q subunit of the first component of complement. Biochemistry 15:5175-5181.
32. Shackelford, P. G., D. M. Granoff, M. H. Nahm, M. G. Scott, B. Suarez, and S. J. Nelson. 1985. Correlation of serum immunoglobulin subclass concentrations with antibody responses of children to immunization with Haemophilus influenzae type b polysaccharide-pertussis vaccine. J. Clin. Immunol. 5:390-395.
33. Siber, G. R., P. H. Schur, A. C. Aisenberg, S. A. Weitzman, and G. Schiffman. 1980. Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. N. Engl. J. Med. 303:178-182.
34. Skevakis, L., C. E. Frasch, J. M. Zahradnik, and R. Dolin. 1984. Classspecific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis. J. Infect. Dis. 149:387-396.
35. Stein, K. E. 1992. Thymus-independent and thymus-dependent responses to polysaccharide antigens. J. Infect. Dis. 165:S49-S52.
36. Taunay, A., P. A. Galvao, J. S. de Morais, E. C. Gotschlich, and R. A. Feldman. 1974. Disease prevention by meningococcal serogroup C polysaccharide vaccine in preschool children: results after eleven months in Sao Paulo, Brazil. Pediatr. Res. 8:429A.
37. Wahdan, M. H., A. A. Sallam, M. N. Hassan, A. Abdel Gawad, A. S. Rakha, J. E. Sippel, R. Hablas, W. R. Sanborn, N. M. Kassem, S. M. Riad, and B. Cvjetanovic. 1977. A second controlled field trial of a serogroup A meningococcal polysaccharide vaccine in Alexandria. Bull. W. H. O. 55:645-651.
38. Weibel, R. E., V. M. Villarejos, P. P. Vella, A. F. Woodhour, A. A. Mclean, and M. R. Hilleman. 1976. Clinical and laboratory investigations of monovalent and combined meningococcal polysaccharide vaccine, groups A and C. Proc. Soc. Exp. Biol. Med. 153:436-440.
39. World Health Organization. 1976. Requirements for meningococcal poly-saccharide vaccine (requirements for biological substances no 23). WHO Tech. Rep. Ser. 594:72-73.
40. Zangwill, K. M., R. W. Stout, G. M. Carlone, L. Pais, H. Harakeh, S. Mitchell, W. H. Wolfe, V. Blackwood, B. D. Plikaytis, and J. E. Wenger. 1994. Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnel. J. Infect. Dis. 169:847-852.